肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

中国肝癌早筛策略专家共识

2021-06-29 全国多中心前瞻性肝癌极早期预警筛查项目 中华肝脏病杂志

肝癌

原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。

中文标题：

中国肝癌早筛策略专家共识

发布机构：

全国多中心前瞻性肝癌极早期预警筛查项目

发布日期：

2021-06-29

简要介绍：

原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。全国多中心前瞻性肝癌极早期预警筛查项目(Prospective suRveillance for very Early hepatoCellular cARcinoma,PreCar)专家组基于国内外主要相关指南、临床实践和PreCar项目研究最新进展,提出了中国早期肝癌筛查策略和具体流程,旨在为早期肝癌筛查和诊断提供实际方法,提高我国防控水平。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=中国肝癌早筛策略专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=331791c002193e62, title=中国肝癌早筛策略专家共识, enTitle=, guiderFrom=中华肝脏病杂志, authorId=0, author=, summary=原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。, cover=https://img.medsci.cn/2021927/1632750868868_5579292.jpg, journalId=0, articlesId=null, associationId=1987, associationName=全国多中心前瞻性肝癌极早期预警筛查项目, associationIntro=全国多中心前瞻性肝癌极早期预警筛查项目(PreCar)专家组, copyright=0, guiderPublishedTime=Tue Jun 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">原发性肝细胞癌是全世界常见的恶性肿瘤之一,每年一半的新发肝癌发生在中国。大量临床研究和实践证明早筛和早诊可有效降低肝癌的5年总病死率。因此探索建立适合中国国情的肝癌筛查策略极其迫切。全国多中心前瞻性肝癌极早期预警筛查项目(Prospective suRveillance for very Early hepatoCellular cARcinoma,PreCar)专家组基于国内外主要相关指南、临床实践和PreCar项目研究最新进展,提出了中国早期肝癌筛查策略和具体流程,旨在为早期肝癌筛查和诊断提供实际方法,提高我国防控水平。&nbsp;</span></p>, tagList=[TagDto(tagId=429, tagName=肝癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=429, guiderKeyword=肝癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5539, appHits=184, showAppHits=0, pcHits=1773, showPcHits=5355, likes=1, shares=6, comments=8, approvalStatus=1, publishedTime=Mon Sep 27 21:57:28 CST 2021, publishedTimeString=2021-06-29, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Sep 27 21:53:22 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 10:44:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国肝癌早筛策略专家共识.pdf)])
中国肝癌早筛策略专家共识.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2022-01-21 ms1000001107271726

    学习了，真好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-12-20 ms5000000464933653

    早筛早治疗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-11-02 燕子Yvonne

    早诊早筛

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-10-08 ms2000001690313017

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1186811, encodeId=f21611868119d, content=学习了，真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=457d5614441, createdName=ms1000001107271726, createdTime=Fri Jan 21 14:08:53 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082214, encodeId=dae6108221430, content=早筛早治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8415716167, createdName=ms5000000464933653, createdTime=Mon Dec 20 20:43:58 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066053, encodeId=714710660531f, content=早诊早筛, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81c35534500, createdName=燕子Yvonne, createdTime=Tue Nov 02 01:00:06 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058730, encodeId=a28f1058e3000, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69995628636, createdName=ms2000001690313017, createdTime=Fri Oct 08 21:53:50 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055657, encodeId=7d7a105565e6e, content=好的很的文章，多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:50:02 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-28 13f0c37dm61暂无昵称

    好的很的文章，多多学习

    0

相关指南

肝癌转化治疗中国专家共识（2021版）

中国抗癌协会肝癌专业委员会(CSLC,Chinese Society of Liver Cancer) · 2021-06-24

原发性肝癌的分层筛查与监测指南（2020版）

中华预防医学会(CPMA,Chinese Preventive Medicine Association) · 2021-01-27

中国肝癌多学科综合治疗专家共识

中国抗癌协会肝癌专业委员会(CSLC,Chinese Society of Liver Cancer) · 2020-12-20

影像引导肝癌的冷冻消融治疗专家共识（2020 版）

亚洲冷冻治疗学会 · 2020-05-05

中国肝癌一级预防专家共识（2018）

中华预防医学会(CPMA,Chinese Preventive Medicine Association) · 2018-09-01

【指南专题】3.18全国护肝日，踢开肝癌，最新肝癌指南汇总

暂未更新 · 2017-03-17

拓展阅读

2010 NACB医学实践指南：肝癌、膀胱癌、子宫颈癌、胃癌肿瘤标志物的应用

美国临床生化科学院(NACB,The National Academy of Clinical Biochemistry) · 2010-01-01

2011 CSLC/CSCO/CMA肝癌射频消融治疗规范的专家共识

中国抗癌协会肝癌专业委员会(CSLC,Chinese Society of Liver Cancer) · 2011-01-01

2011原发性肝癌局部消融治疗的专家共识

中国抗癌协会肝癌专业委员会(CSLC,Chinese Society of Liver Cancer) · 2011-01-01

2011 原发性肝癌规范化病理诊断方案专家共识

中国抗癌协会肝癌专业委员会(CSLC,Chinese Society of Liver Cancer) · 2011-04-01

原发性肝癌诊疗规范(2011年版)

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-10-14

中国肝癌肝移植临床实践指南（2014版）

中华医学会器官移植学分会 · 2014-07-15